NGENF Message Board Post 10044090 | NervGen Pharma Corp -...
home / stock / ngenf / ngenf message board
njd
(investorshub)
Posted on: Jul/28/2022 15:16:02
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169521999
getting found,scanners blowing up
News, Short Squeeze, Breakout and More Instantly...
NervGen Pharma Corp Company Name:
NGENF Stock Symbol:
Market:
-
Vancouver, British Columbia--(Newsfile Corp. - May 17, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced today that Daniel Mikol, MD, Ph.D., Chief Medical ...
-
Target for completing enrollment of the chronic cohort in the Phase 1b/2a clinical trial moved to Q3 2024 Subacute cohort protocol being amended to enhance feasibility and lessen burden on participants CA$23 million bought deal financing completed in March 2024 provides expected cash runway...
-
Bill Radvak to transition to Board Advisor following decision to not stand for re-election to NervGen's Board of Directors Annual General Meeting of Shareholders to be held on June 4, 2024 Vancouver, British Columbia--(Newsfile Corp. - May 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQ...